Increased levels of the calcification marker matrix Gla Protein and the inflammatory markers YKL-40 and CRP in patients with type 2 diabetes and ischemic heart disease

Stine B Thomsen; Camilla N Rathcke; Bo Zerahn; Henrik Vestergaard

doi:10.1186/1475-2840-9-86

Increased levels of the calcification marker matrix Gla Protein and the inflammatory markers YKL-40 and CRP in patients with type 2 diabetes and ischemic heart disease

Stine B Thomsen, Camilla N Rathcke, Bo Zerahn, Henrik Vestergaard

52 Citationer (Scopus)

Abstract

Low grade inflammation is of pathogenic importance in atherosclerosis and in the development of cardiovascular disease (CVD) and type 2 diabetes (T2D). Matrix GLA protein (MGP), an inhibitor of medial calcification of arteries, is increased in patients with atherosclerosis. In the present study levels of markers of calcification (MGP) and inflammation (YKL-40, hsCRP) were evaluated in patients with T2 D and/or ischemic heart disease (IHD).

Originalsprog	Engelsk
Tidsskrift	Cardiovascular Diabetology
Vol/bind	9
Sider (fra-til)	86
ISSN	1475-2840
DOI	https://doi.org/10.1186/1475-2840-9-86
Status	Udgivet - 1 jan. 2010

Adgang til dokumentet

10.1186/1475-2840-9-86

Citationsformater

Increased levels of the calcification marker matrix Gla Protein and the inflammatory markers YKL-40 and CRP in patients with type 2 diabetes and ischemic heart disease. / Thomsen, Stine B; Rathcke, Camilla N; Zerahn, Bo et al.
I: Cardiovascular Diabetology, Bind 9, 01.01.2010, s. 86.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

@article{c3f39749301f4eab885048a77726fcfd,

title = "Increased levels of the calcification marker matrix Gla Protein and the inflammatory markers YKL-40 and CRP in patients with type 2 diabetes and ischemic heart disease",

abstract = "Low grade inflammation is of pathogenic importance in atherosclerosis and in the development of cardiovascular disease (CVD) and type 2 diabetes (T2D). Matrix GLA protein (MGP), an inhibitor of medial calcification of arteries, is increased in patients with atherosclerosis. In the present study levels of markers of calcification (MGP) and inflammation (YKL-40, hsCRP) were evaluated in patients with T2 D and/or ischemic heart disease (IHD).",

author = "Thomsen, {Stine B} and Rathcke, {Camilla N} and Bo Zerahn and Henrik Vestergaard",

year = "2010",

month = jan,

day = "1",

doi = "10.1186/1475-2840-9-86",

language = "English",

volume = "9",

pages = "86",

journal = "Cardiovascular Diabetology",

issn = "1475-2840",

publisher = "BioMed Central Ltd",

}

TY - JOUR

T1 - Increased levels of the calcification marker matrix Gla Protein and the inflammatory markers YKL-40 and CRP in patients with type 2 diabetes and ischemic heart disease

AU - Thomsen, Stine B

AU - Rathcke, Camilla N

AU - Zerahn, Bo

AU - Vestergaard, Henrik

PY - 2010/1/1

Y1 - 2010/1/1

N2 - Low grade inflammation is of pathogenic importance in atherosclerosis and in the development of cardiovascular disease (CVD) and type 2 diabetes (T2D). Matrix GLA protein (MGP), an inhibitor of medial calcification of arteries, is increased in patients with atherosclerosis. In the present study levels of markers of calcification (MGP) and inflammation (YKL-40, hsCRP) were evaluated in patients with T2 D and/or ischemic heart disease (IHD).

AB - Low grade inflammation is of pathogenic importance in atherosclerosis and in the development of cardiovascular disease (CVD) and type 2 diabetes (T2D). Matrix GLA protein (MGP), an inhibitor of medial calcification of arteries, is increased in patients with atherosclerosis. In the present study levels of markers of calcification (MGP) and inflammation (YKL-40, hsCRP) were evaluated in patients with T2 D and/or ischemic heart disease (IHD).

U2 - 10.1186/1475-2840-9-86

DO - 10.1186/1475-2840-9-86

M3 - Journal article

C2 - 21143859

SN - 1475-2840

VL - 9

SP - 86

JO - Cardiovascular Diabetology

JF - Cardiovascular Diabetology

ER -

Increased levels of the calcification marker matrix Gla Protein and the inflammatory markers YKL-40 and CRP in patients with type 2 diabetes and ischemic heart disease

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater